Does USTEKINUMAB Cause Lymphoma? 116 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 116 reports of Lymphoma have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 0.1% of all adverse event reports for USTEKINUMAB.
116
Reports of Lymphoma with USTEKINUMAB
0.1%
of all USTEKINUMAB reports
7
Deaths
30
Hospitalizations
How Dangerous Is Lymphoma From USTEKINUMAB?
Of the 116 reports, 7 (6.0%) resulted in death, 30 (25.9%) required hospitalization, and 8 (6.9%) were considered life-threatening.
Is Lymphoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 116 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
What Other Drugs Cause Lymphoma?
RANITIDINE (1,256)
RITUXIMAB (1,216)
ADALIMUMAB (982)
METHOTREXATE (861)
ETANERCEPT (697)
INFLIXIMAB (671)
CYCLOPHOSPHAMIDE (640)
LENALIDOMIDE (518)
PREDNISONE (490)
VINCRISTINE (422)
Which USTEKINUMAB Alternatives Have Lower Lymphoma Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE